Elevated Sp1 levels have been reported in multiple cancers, including gastric cancer (GC), ovarian cancer, pancreatic cancer, hepatocellular carcinoma, glioblastoma, lung cancer, breast cancer, and colorectal cancer (CRC). This evidence concerns the gene SP1 and breast cancer.